MediWound Ltd. — Investor Relations & Filings
Filings indexed
370
across all filing types
Latest filing
2026-05-27
Regulatory Filings
Country
IL
Israel
Listing
US
MDWD
MediWound Ltd. is a fully integrated biopharmaceutical company that develops, manufactures, and commercializes enzymatic therapeutics for non-surgical tissue repair. The company's core technology focuses on next-generation treatments that selectively remove eschar (non-viable tissue) from severe burns and chronic wounds while preserving healthy tissue. This approach is designed to accelerate healing, improve patient outcomes, and lower overall healthcare costs. Its primary commercial product is a topical biologic for the debridement of severe thermal burns. MediWound maintains a research and development pipeline aimed at expanding its enzymatic platform to address additional unmet medical needs in wound care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2026-05-27 | English | |
| 6-K - MediWound Ltd. (0001593984) (Filer) | 2026-04-02 | English | |
| 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-25 | English | |
| 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | |
| 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | |
| 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 47465039 | 6-K | 2026-05-27 | English | ||
| 33192505 | 6-K - MediWound Ltd. (0001593984) (Filer) | 2026-04-02 | English | ||
| 33039396 | 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-25 | English | ||
| 32979821 | 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | ||
| 32979805 | 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | ||
| 32980027 | 3 - MediWound Ltd. (0001593984) (Issuer) | 2026-03-18 | English | ||
| 30796114 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30796102 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 30796091 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 30795971 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 30796127 | 6-K Filing | 2026-01-15 | English | ||
| 12733058 | 6-K | 2026-01-12 | English | ||
|
2025
3 filings
| |||||
| 12733057 | Regulatory Filings 2025 | 2025-12-03 | English | ||
| 12733059 | 6-K | 2025-11-20 | English | ||
| 12733060 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Amylyx Pharmaceuticals, Inc.
Develops therapies for neurodegenerative diseases and other…
|
AMLX | US | Manufacturing |
|
AN2 Therapeutics, Inc.
Biopharmaceutical firm developing boron-based drugs for inf…
|
ANTX | US | Manufacturing |
|
Ananda Pharma Plc
Biopharmaceutical firm developing cannabinoid-based medicin…
|
ANAN | GB | Manufacturing |
|
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
Designs, develops, and manufactures molecular diagnostic so…
|
ANGEN | TR | Manufacturing |
|
ANAVEX LIFE SCIENCES CORP.
Clinical-stage biopharmaceutical company developing therape…
|
AVXL | US | Manufacturing |
|
Anbio Biotechnology
Develops and provides in-vitro diagnostic (IVD) solutions a…
|
NNNN | KY | Manufacturing |
|
Anebulo Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for acute canna…
|
ANEB | US | Manufacturing |
|
AnGes, Inc.
Biopharmaceutical firm developing gene-based and nucleotide…
|
4563 | JP | Manufacturing |
|
ANG Lifesciences India Limited
Develops and manufactures sterile dry powder and liquid inj…
|
540694 | IN | Manufacturing |
|
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD.
Develops biopharmaceuticals, genetic engineering products, …
|
300009 | CN | Manufacturing |
MediWound Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33721/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33721 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33721 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33721 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33721}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MediWound Ltd. (id: 33721)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.